ESCRT-mediated phagophore sealing during mitophagy.


Journal

Autophagy
ISSN: 1554-8635
Titre abrégé: Autophagy
Pays: United States
ID NLM: 101265188

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 2 8 2019
medline: 8 6 2021
entrez: 2 8 2019
Statut: ppublish

Résumé

Inactivation of the endosomal sorting complex required for transport (ESCRT) machinery has been reported to cause autophagic defects, but the exact functions of ESCRT proteins in macroautophagy/autophagy remain incompletely understood. Using live-cell fluorescence microscopy we found that the filament-forming ESCRT-III subunit CHMP4B was recruited transiently to nascent autophagosomes during starvation-induced autophagy and mitophagy, with residence times of about 1 and 2 min, respectively. Correlative light microscopy and electron tomography revealed CHMP4B recruitment at a late step in mitophagosome formation. The autophagosomal dwell time of CHMP4B was strongly increased by depletion of the regulatory ESCRT-III subunit CHMP2A. Using a novel optogenetic closure assay we observed that depletion of CHMP2A inhibited phagophore sealing during mitophagy. Consistent with this, depletion of CHMP2A and other ESCRT-III subunits inhibited both PRKN/PARKIN-dependent and -independent mitophagy. We conclude that the ESCRT machinery mediates phagophore closure, and that this is essential for mitophagic flux.

Identifiants

pubmed: 31366282
doi: 10.1080/15548627.2019.1639301
pmc: PMC7158923
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

826-841

Références

Nat Cell Biol. 2010 Apr;12(4):362-71
pubmed: 20208530
Curr Pharm Des. 2013;19(30):5437-42
pubmed: 23431986
Nat Rev Mol Cell Biol. 2004 Apr;5(4):317-23
pubmed: 15071556
Science. 2014 Feb 28;343(6174):1247136
pubmed: 24482116
Autophagy. 2016;12(1):1-222
pubmed: 26799652
PLoS One. 2009 Aug 06;4(8):e6529
pubmed: 19657394
Cell Struct Funct. 2002 Feb;27(1):29-37
pubmed: 11937716
Science. 2007 Jun 29;316(5833):1908-12
pubmed: 17556548
Cell. 2012 Dec 7;151(6):1256-69
pubmed: 23217709
J Cell Biol. 2019 Jun 3;218(6):1908-1927
pubmed: 31010855
Cell Struct Funct. 1997 Oct;22(5):501-9
pubmed: 9431454
J Biol Chem. 1998 Aug 21;273(34):21883-92
pubmed: 9705327
Cell. 1990 Jul 27;62(2):317-29
pubmed: 2115402
EMBO Rep. 2018 Apr;19(4):
pubmed: 29437695
Science. 2016 Apr 15;352(6283):353-8
pubmed: 27013428
J Cell Sci. 2012 Feb 1;125(Pt 3):685-94
pubmed: 22389403
Nat Commun. 2018 Jul 20;9(1):2855
pubmed: 30030437
Cold Spring Harb Perspect Biol. 2013 Sep 01;5(9):
pubmed: 24003212
Cell. 2001 Jul 27;106(2):145-55
pubmed: 11511343
Curr Opin Cell Biol. 2010 Apr;22(2):124-31
pubmed: 20034776
J Cell Biol. 2016 Feb 29;212(5):499-513
pubmed: 26929449
Dev Cell. 2002 Aug;3(2):271-82
pubmed: 12194857
Curr Biol. 2007 Sep 18;17(18):1561-7
pubmed: 17683935
J Cell Biol. 2007 Nov 5;179(3):485-500
pubmed: 17984323
Nature. 2015 Jun 11;522(7555):236-9
pubmed: 26040713
Science. 2018 Apr 6;360(6384):
pubmed: 29622626
Curr Biol. 2007 Oct 23;17(20):1817-25
pubmed: 17935992
Dev Cell. 2008 Oct;15(4):578-89
pubmed: 18854142
Nat Rev Mol Cell Biol. 2002 Dec;3(12):893-905
pubmed: 12461556
Science. 2016 Apr 15;352(6283):359-62
pubmed: 27013426
Science. 2011 Mar 25;331(6024):1616-20
pubmed: 21310966
J Cell Biol. 2014 Sep 15;206(6):763-77
pubmed: 25202029
EMBO J. 2015 Oct 1;34(19):2398-407
pubmed: 26311197
Nat Commun. 2018 Jul 26;9(1):2932
pubmed: 30050131
Dev Cell. 2019 May 20;49(4):509-525.e12
pubmed: 30982665
EMBO J. 2018 Nov 2;37(21):
pubmed: 30314966
Curr Biol. 2018 Feb 19;28(4):R170-R185
pubmed: 29462587
Nat Rev Mol Cell Biol. 2017 Jan;18(1):5-17
pubmed: 27703243
Trends Biochem Sci. 2017 Jan;42(1):42-56
pubmed: 27669649
Autophagy. 2015 Nov 2;11(11):2134-2137
pubmed: 26466816
J Cell Sci. 2015 Jan 15;128(2):193-205
pubmed: 25568151
EMBO J. 2000 Nov 1;19(21):5720-8
pubmed: 11060023
Nature. 2015 Jun 11;522(7555):231-5
pubmed: 26040712
J Cell Sci. 2009 Jul 1;122(Pt 13):2179-83
pubmed: 19535733
EMBO Rep. 2013 Dec;14(12):1127-35
pubmed: 24176932
Genome Biol. 2006;7(10):R100
pubmed: 17076895
Nat Methods. 2016 Sep;13(9):755-8
pubmed: 27427858
J Cell Biol. 2014 Nov 10;207(3):419-32
pubmed: 25385186

Auteurs

Yan Zhen (Y)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norway.

Hélène Spangenberg (H)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norway.

Michael J Munson (MJ)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway.
Department of Molecular Medicine, Institute of Basic Medical Sciences, Oslo, Norway.

Andreas Brech (A)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norway.

Kay O Schink (KO)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norway.

Kia-Wee Tan (KW)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norway.

Vigdis Sørensen (V)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norway.

Eva Maria Wenzel (EM)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norway.

Maja Radulovic (M)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norway.

Nikolai Engedal (N)

Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway.

Anne Simonsen (A)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway.
Department of Molecular Medicine, Institute of Basic Medical Sciences, Oslo, Norway.

Camilla Raiborg (C)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norway.

Harald Stenmark (H)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH